Progress and perspectives of platinum nanozyme in cancer therapy
Open Access
- 2 December 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 10, 1092747
Abstract
Malignant tumors, one of the worst-case scenarios within human health problems, are now posing an increasing threat to the well-being of the global population. At present, the treatment of malignant tumors mainly includes surgery, radiotherapy, chemotherapy, immunotherapy, etc. Radiotherapy and chemotherapy are often applied to inoperable tumors, and some other tumors after surgery as important adjuvant therapies. Nonetheless, both radiotherapy and chemotherapy have a series of side effects, such as radiation-induced lung injury, and chemotherapy-induced bone marrow suppression. In addition, the positioning accuracy of radiotherapy and chemotherapy is not assured and satisfactory, and the possibility of tumor cells not being sensitive to radiation and chemotherapy drugs is also problematic. Nanozymes are nanomaterials that display natural enzyme activities, and their applications to tumor therapy have made great progress recently. The most studied one, platinum nanozyme, has been shown to possess a significant correlation with radiotherapy sensitization of tumors as well as photodynamic therapy. However, there are still several issues that limited the usage of platinum-based nanozymes in vivo. In this review, we briefly summarize the representative studies regarding platinum nanozymes, and especially emphasize on the current challenges and the directions of future development for platinum nanozymes therapy.Keywords
Funding Information
- National Natural Science Foundation of China (82130092)
This publication has 68 references indexed in Scilit:
- Modern Radiotherapy Concepts and the Impact of Radiation on Immune ActivationFrontiers in Oncology, 2016
- Hypoxic control of metastasisScience, 2016
- Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapyNature Communications, 2015
- Hemoglobin‐Based Nanoarchitectonic Assemblies as Oxygen CarriersAdvanced Materials, 2015
- Elucidating the Fundamental Mechanisms of Cell Death Triggered by Photothermal TherapyACS Nano, 2015
- Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxiaBritish Journal of Cancer, 2013
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapyTrends in Pharmacological Sciences, 2012
- Dying cell clearance and its impact on the outcome of tumor radiotherapyFrontiers in Oncology, 2012
- Primary Analysis of a Phase II Randomized Trial Radiation Therapy Oncology Group (RTOG) 0212: Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients With Limited-Disease Small-Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Exploiting tumour hypoxia in cancer treatmentNature Reviews Cancer, 2004